AGR2-high cells drive a FOXM1-mediated pro-malignancy program in non-functional pancreatic neuroendocrine tumors (NF-PanNETs) and informatively predict patient outcomes
Authors:
- 6 June 2026
- journal article
- Published by Elsevier in Science Bulletin
- Vol. 71 (16) , 4138-4143
Abstract
No abstract availableFunding Information
- University Grants Committee (GRF 14300923)
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2021-I2M-1-002)
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2023-I2M-2-002)
- Chinese University of Hong Kong (2025/26)
- Research Grants Council, University Grants Committee
- Peking Union Medical College (UBJ11753)
- National Natural Science Foundation of China (12501672)
- National Natural Science Foundation of China (82141102 and12501672)
This publication has 11 references indexed in Scilit:
- Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumorsBritish Journal of Cancer, 2024
- European Neuroendocrine Tumour Society (ENETS) 2023 guidance paper for nonfunctioning pancreatic neuroendocrine tumoursJournal of Neuroendocrinology, 2023
- Cancer Cells Retrace a Stepwise Differentiation Program during Malignant ProgressionCancer Discovery, 2021
- Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour sizeGut, 2021
- Whole-genome sequencing reveals distinct genetic bases for insulinomas and non-functional pancreatic neuroendocrine tumours: leading to a new classification systemGut, 2019
- Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United StatesJAMA Oncology, 2017
- A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic CharacteristicsCancer Discovery, 2015
- Whole-exome characterization of pancreatic neuroendocrine tumor cell lines BON-1 and QGP-1Journal of Molecular Endocrinology, 2015
- Suppression of the FOXM1 transcriptional programme via novel small molecule inhibitionNature Communications, 2014
- The transcription factor FOXM1 is a cellular target of the natural product thiostreptonNature Chemistry, 2011